156 related articles for article (PubMed ID: 31961011)
1. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
[TBL] [Abstract][Full Text] [Related]
2. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
[TBL] [Abstract][Full Text] [Related]
3. [Divergence Analysis of Hepatitis Virus Infection between Aggressive and Indolent B Cell Non-Hodgkin's Lymphoma].
Xiong WJ; Li H; Liu HM; Yi SH; Li ZJ; Lu R; Liu W; Zou DH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1754-1758. PubMed ID: 28024489
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
[TBL] [Abstract][Full Text] [Related]
5. Inferior survival and frequent hepatic dysfunction in non-Hodgkin's lymphoma patients with HBV infection: a systematic review and meta-analysis.
Zhang MY; Gao F; Zhao YW; Ni BW; Huang HH; Hou J
Hematology; 2022 Dec; 27(1):70-79. PubMed ID: 34957924
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.
Ozguroglu M; Bilici A; Turna H; Serdengecti S
Med Oncol; 2004; 21(1):67-72. PubMed ID: 15034216
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
[TBL] [Abstract][Full Text] [Related]
9. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.
Chen J; Wang J; Yang J; Zhang W; Song X; Chen L
PLoS One; 2013; 8(7):e69400. PubMed ID: 23861969
[TBL] [Abstract][Full Text] [Related]
10. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
Huang CE; Yang YH; Chen YY; Chang JJ; Chen KJ; Lu CH; Lee KD; Chen PC; Chen CC
J Viral Hepat; 2017 Oct; 24(10):885-894. PubMed ID: 28375587
[TBL] [Abstract][Full Text] [Related]
11. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
12. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
[TBL] [Abstract][Full Text] [Related]
13. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
Dalia S; Chavez J; Castillo JJ; Sokol L
Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.
Becker N; Schnitzler P; Boffetta P; Brennan P; Foretova L; Maynadié M; Nieters A; Staines A; Benavente Y; Cocco P; de Sanjose S
J Cancer Res Clin Oncol; 2012 Dec; 138(12):1993-2001. PubMed ID: 22767316
[TBL] [Abstract][Full Text] [Related]
17. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis.
Nath A; Agarwal R; Malhotra P; Varma S
Intern Med J; 2010 Sep; 40(9):633-41. PubMed ID: 19811561
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
Li M; Shen Y; Chen Y; Gao H; Zhou J; Wang Q; Fan C; Zhang W; Li J; Cong H; Gu J; Gan Y; Tu H
Int J Cancer; 2020 Oct; 147(8):2199-2209. PubMed ID: 32350851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
